We are live on ! Find out more
STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Stemline Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 94 → 0 (-94)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $194M → $0 (-$194M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 94

Holders
–
Holders Change
-94
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
94
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
-$20.1M
2
BlackRock
BlackRock
New York
-$18.1M
3
RCMNY
Rubric Capital Management (New York)
New York
-$16.2M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$14.9M
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$12.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCFM
76
Clear Creek Financial Management
Washington
– -$79K -15,000 Closed
State Board of Administration of Florida Retirement System
77
State Board of Administration of Florida Retirement System
Florida
– -$68K -14,138 Closed
MLICM
78
Metropolitan Life Insurance Company (MetLife)
New York
– -$66.4K -13,714 Closed
PPA
79
Parametric Portfolio Associates
Washington
– -$51K -10,612 Closed
ASRS
80
Arizona State Retirement System
Arizona
– -$51K -10,592 Closed
Legal & General Group
81
Legal & General Group
United Kingdom
– -$43K -8,927 Closed
SPIA
82
Steward Partners Investment Advisory
New York
– -$21K -4,400 Closed
Zurich Cantonal Bank
83
Zurich Cantonal Bank
Switzerland
– -$21K -4,297 Closed
AIP
84
Ameritas Investment Partners
Nebraska
– -$19K -3,938 Closed
Royal Bank of Canada
85
Royal Bank of Canada
Ontario, Canada
– -$16K -3,238 Closed
BWP
86
Baldwin Wealth Partners
Massachusetts
– -$15K -3,100 Closed
Canada Life
87
Canada Life
Manitoba, Canada
– -$13K -2,733 Closed
Simplex Trading
88
Simplex Trading
Illinois
– -$10K -2,172 Closed
MAM
89
Meeder Asset Management
Ohio
– -$5K -1,120 Closed
EWM
90
Edge Wealth Management
New York
– -$2K -500 Closed
US Bancorp
91
US Bancorp
Minnesota
– -$2K -500 Closed
SWM
92
Sugarloaf Wealth Management
Georgia
– -$1K -300 Closed
1 2 3
4

STML Hedge Fund Activity: Q2 2020 in Review

0 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Stemline Therapeutics, Inc. (STML) for Q2 2020, worth a combined $0 — down 100% from $194M a quarter earlier.

Sellers outnumbered buyers: 94 funds closed out of STML and 0 opened new positions — a net loss of 94 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Eventide Asset Management, exiting entirely with an estimated $20.1M sold.

  • 0 institutional investors held Stemline Therapeutics, Inc. (STML) as of Q2 2020, down from 94 in Q1 2020.
  • Funds reported $0 of Stemline Therapeutics, Inc. stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Stemline Therapeutics, Inc. positions in Q2 2020 and 94 closed out, a net change of -94 holders.
  • The largest Stemline Therapeutics, Inc. seller in Q2 2020 was Eventide Asset Management, an estimated $20.1M sold.

Based on aggregated 13F filings for Q2 2020.